Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Imatinib Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Imatinib Drugsmarket, defines the market attractiveness level of Imatinib Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Imatinib Drugs industry, describes the types of Imatinib Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Imatinib Drugs market and the development prospects and opportunities of Imatinib Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Imatinib Drugs market in Chapter 13.
By Player:
Teva Pharmaceutical Industries Ltd
Novartis
Apotex Inc
Mylan Pharms Inc
Sanofi SA
Actavis Generics
Cipla Inc
Dr Reddy's Laboratories
Sun Pharmaceuticals
Glenmark Pharmaceuticals Ltd
By Type:
Capsules
Tablets
By End-User:
Hospitals
Drug Stores
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Imatinib Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Imatinib Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Imatinib Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Imatinib Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Imatinib Drugs Market Analysis and Outlook to 2022
-
7.1 Global Imatinib Drugs Consumption (2017-2022)
-
7.2 United States Imatinib Drugs Consumption (2017-2022)
-
7.3 Europe Imatinib Drugs Consumption (2017-2022)
-
7.4 China Imatinib Drugs Consumption (2017-2022)
-
7.5 Japan Imatinib Drugs Consumption (2017-2022)
-
7.6 India Imatinib Drugs Consumption (2017-2022)
-
7.7 South Korea Imatinib Drugs Consumption (2017-2022)
8 Region and Country-wise Imatinib Drugs Market Analysis and Outlook to 2028
-
8.1 Global Imatinib Drugs Consumption Forecast (2022-2028)
-
8.2 United States Imatinib Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Imatinib Drugs Consumption Forecast (2022-2028)
-
8.4 China Imatinib Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Imatinib Drugs Consumption Forecast (2022-2028)
-
8.6 India Imatinib Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Imatinib Drugs Consumption Forecast (2022-2028)
9 Global Imatinib Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Imatinib Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Capsules Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Tablets Consumption and Growth Rate (2017-2022)
-
9.2 Global Imatinib Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drug Stores Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Imatinib Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Imatinib Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Imatinib Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Imatinib Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Imatinib Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Imatinib Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Imatinib Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Imatinib Drugs Market Competitive Analysis
-
14.1 Teva Pharmaceutical Industries Ltd
-
14.1.1 Teva Pharmaceutical Industries Ltd Company Details
-
14.1.2 Teva Pharmaceutical Industries Ltd Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Teva Pharmaceutical Industries Ltd Imatinib Drugs Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Imatinib Drugs Product and Service
-
14.3 Apotex Inc
-
14.3.1 Apotex Inc Company Details
-
14.3.2 Apotex Inc Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Apotex Inc Imatinib Drugs Product and Service
-
14.4 Mylan Pharms Inc
-
14.4.1 Mylan Pharms Inc Company Details
-
14.4.2 Mylan Pharms Inc Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Mylan Pharms Inc Imatinib Drugs Product and Service
-
14.5 Sanofi SA
-
14.5.1 Sanofi SA Company Details
-
14.5.2 Sanofi SA Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sanofi SA Imatinib Drugs Product and Service
-
14.6 Actavis Generics
-
14.6.1 Actavis Generics Company Details
-
14.6.2 Actavis Generics Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Actavis Generics Imatinib Drugs Product and Service
-
14.7 Cipla Inc
-
14.7.1 Cipla Inc Company Details
-
14.7.2 Cipla Inc Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Cipla Inc Imatinib Drugs Product and Service
-
14.8 Dr Reddy's Laboratories
-
14.8.1 Dr Reddy's Laboratories Company Details
-
14.8.2 Dr Reddy's Laboratories Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Dr Reddy's Laboratories Imatinib Drugs Product and Service
-
14.9 Sun Pharmaceuticals
-
14.9.1 Sun Pharmaceuticals Company Details
-
14.9.2 Sun Pharmaceuticals Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sun Pharmaceuticals Imatinib Drugs Product and Service
-
14.10 Glenmark Pharmaceuticals Ltd
-
14.10.1 Glenmark Pharmaceuticals Ltd Company Details
-
14.10.2 Glenmark Pharmaceuticals Ltd Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Glenmark Pharmaceuticals Ltd Imatinib Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Imatinib Drugs
-
Figure Imatinib Drugs Picture
-
Table Global Imatinib Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Imatinib Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Imatinib Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Imatinib Drugs Consumption by Country (2017-2022)
-
Figure United States Imatinib Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Imatinib Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Imatinib Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Imatinib Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Imatinib Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Imatinib Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Imatinib Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Imatinib Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Imatinib Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Imatinib Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Imatinib Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Imatinib Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Imatinib Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Imatinib Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Imatinib Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Imatinib Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Imatinib Drugs Product and Service
-
Table Apotex Inc (Foundation Year, Company Profile and etc.)
-
Table Apotex Inc Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apotex Inc Imatinib Drugs Product and Service
-
Table Mylan Pharms Inc (Foundation Year, Company Profile and etc.)
-
Table Mylan Pharms Inc Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Pharms Inc Imatinib Drugs Product and Service
-
Table Sanofi SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi SA Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Imatinib Drugs Product and Service
-
Table Actavis Generics (Foundation Year, Company Profile and etc.)
-
Table Actavis Generics Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis Generics Imatinib Drugs Product and Service
-
Table Cipla Inc (Foundation Year, Company Profile and etc.)
-
Table Cipla Inc Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Inc Imatinib Drugs Product and Service
-
Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)
-
Table Dr Reddy's Laboratories Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy's Laboratories Imatinib Drugs Product and Service
-
Table Sun Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceuticals Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceuticals Imatinib Drugs Product and Service
-
Table Glenmark Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)
-
Table Glenmark Pharmaceuticals Ltd Imatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glenmark Pharmaceuticals Ltd Imatinib Drugs Product and Service
-
